<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0015759"><a href="http://purl.obolibrary.org/obo/MONDO_0015759">MONDO:0015759</a></h3>
<p><strong>Label:</strong> b-cell non-Hodgkin lymphoma</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0015819">MONDO:0015819</a> (indolent primary cutaneous b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015818">MONDO:0015818</a> (aggressive primary cutaneous b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0017595">MONDO:0017595</a> (aggressive b-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0007243">MONDO:0007243</a> (Burkitts lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0004948">MONDO:0004948</a> (chronic lymphocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0018905">MONDO:0018905</a> (diffuse large b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0017594">MONDO:0017594</a> (indolent b-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0018906">MONDO:0018906</a> (follicular lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0007926">MONDO:0007926</a> (Waldenstrom macroglobulinemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020511">MONDO:0020511</a> (precursor b-cell acute lymphoblastic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0017604">MONDO:0017604</a> (marginal zone lymphoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_99860">Orphanet:99860</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178557">Orphanet:178557</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300846">Orphanet:300846</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300912">Orphanet:300912</a>, <a href="http://www.orpha.net/ORDO/Orphanet_33226">Orphanet:33226</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300842">Orphanet:300842</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178554">Orphanet:178554</a>, <a href="http://purl.obolibrary.org/obo/OMIM_153600">OMIM:153600</a>, <a href="http://purl.obolibrary.org/obo/OMIM_113970">OMIM:113970</a>, <a href="http://purl.obolibrary.org/obo/OMIM_151400">OMIM:151400</a>, <a href="http://www.orpha.net/ORDO/Orphanet_67038">Orphanet:67038</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613024">OMIM:613024</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610430">OMIM:610430</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615545">OMIM:615545</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612558">OMIM:612558</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612557">OMIM:612557</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609630">OMIM:609630</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612559">OMIM:612559</a>, <a href="http://www.orpha.net/ORDO/Orphanet_544">Orphanet:544</a>, <a href="http://purl.obolibrary.org/obo/OMIM_109543">OMIM:109543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_543">Orphanet:543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_545">Orphanet:545</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 31.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000004">HP:0000004</a> (null))) 31.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000003">HP:0000003</a> (Multicystic kidney dysplasia))) 31.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 30.59%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 30.05%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 25.24%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 24.91%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 24.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 23.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 22.74%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 20.51%</li>
<li>Thing 20.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 20.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 20.15%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 18.11%</li>
</ul>
</body>
</html>
